Quick Answer
HeartBeam, Inc. reported R&D Expense of $13.45 million for fiscal year 2025.
HeartBeam, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $13.45M | +21.7% |
| 2024 | $11.05M | +62.6% |
| 2023 | $6.80M | +19.7% |
| 2022 | $5.68M | +2126.3% |
| 2021 | $255.0K | +91.7% |
| 2020 | $133.0K | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $3.28M | +13.3% | -1.4% |
| June 30, 2025 | $3.33M | +16.9% | -4.8% |
| March 31, 2025 | $3.49M | +43.8% | +20.7% |
| September 30, 2024 | $2.89M | +78.3% | +1.7% |
| June 30, 2024 | $2.84M | +91.6% | +17.1% |
| March 31, 2024 | $2.43M | +44.4% | +49.6% |
| September 30, 2023 | $1.62M | +3.9% | +9.4% |
| June 30, 2023 | $1.48M | -14.8% | -11.7% |
- HeartBeam, Inc. showed an increase of +21.7% in R&D Expense compared to the prior fiscal year.
- Over the 2020–2025 period, HeartBeam, Inc.’s r&d expense has grown by 10012.8% (from $133.0 thousand to $13.45 million).
- The most recent figure is from HeartBeam, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: